Clinical investigations have demonstrated the dysregulation of multiple inflammatory mediators in various forms of PAH, such as IL-1, IL-6, TGF-β, and CCR2 (Figure 2) [12,18,70,71]. The gene discussed is IL1A; the disease is pulmonary arterial hypertension.